Accelerated Oxygen Atom Transfer and C−H Bond Oxygenation by Remote Redox Changes in Fe_3Mn-Iodosobenzene Adducts by De Ruiter, Graham et al.
Supporting Information
Accelerated Oxygen Atom Transfer and CH Bond Oxygenation by
Remote Redox Changes in Fe3Mn-Iodosobenzene Adducts
Graham de Ruiter+, Kurtis M. Carsch+, Sheraz Gul, Ruchira Chatterjee, Niklas B. Thompson,
Michael K. Takase, Junko Yano, and Theodor Agapie*
ange_201701319_sm_miscellaneous_information.pdf
 S2 
Table of Contents. 
 
General Considerations ...............................................................................................................................4 
Physical Methods .........................................................................................................................................4 
Synthetic Procedures ...................................................................................................................................9 
Synthesis of [LFe3(PhPz)3OMn][OTf]2 (1) ....................................................................................................9 
Synthesis of [LFe3(PhPz)3OMn][OTf]3 (2) ....................................................................................................9 
Synthesis of [LFe3(PhPz)3OMn(sPhIO)][OTf]2 (3) .......................................................................................9 
Synthesis of [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4) .....................................................................................10 
Synthesis of [LFe3(PhPz)2(OArPz)OMn][OTf]2 (5) ....................................................................................11 
Synthesis of [LFe3(PhPz)2(OArPz)OMn][OTf]3 (6) ....................................................................................11 
Figure S1. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]2 (1) ..............................................13 
Figure S2. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]3 (2) ..............................................13 
Figure S3. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn(sPhIO)][OTf]2 (3) .................................14 
Figure S4. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4) .................................14 
Figure S5. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OMn][OTf]2 (5) ................................15 
Figure S6. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OMn][OTf]3 (6) ................................15 
Figure S7. VT 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]2 (1) .......................................16 
Figure S8. VT 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]3 (2) .......................................16 
Figure S9. Time dependent 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]2 (1) ...................17 
Figure S10. Time dependent 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]3 (2) .................17 
Figure S11. Cyclic voltammograms of complexes 1 and 5 ........................................................................18 
Figure S12. Normalized Mn K-edge XANES spectra (4.2 K) of compounds 1–6 .....................................19 
Figure S13. Normalized Fe K-edge XANES spectra (4.2 K) of compounds 1–6 ......................................19 
Figure S14. Fourier transforms of the Mn and Fe EXAFS of 1 and 2 ........................................................20 
Figure S15. Fourier transforms of the Mn and Fe EXAFS of 3 and 4 ........................................................21 
Figure S16. Fourier transforms of the Mn and Fe EXAFS of 5 and 6 ........................................................22 
Figure S17. Zero-field 57Fe Mössbauer spectra of 1 and 2 .........................................................................23 
Figure S18.	Zero-field 57Fe Mössbauer spectra of 4 ...................................................................................23 
Figure S19.	Zero-field 57Fe Mössbauer spectra of 5 and 6 .........................................................................24 
Figure S20. Crystal structure of [LFe3(PhPz)3OMn][OTf]2 (1) ..................................................................25 
Special refinement details for complex 1. ....................................................................................................25 
Figure S21. Crystal structure of  [LFe3(PhPz)3OMn(MeCN)][OTf]3 (2) ...................................................26 
 S3 
Special refinement details for complex 2. ....................................................................................................26 
Figure S22. Crystal structure of  [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4) .....................................................27 
Special refinement details for complex 4. ....................................................................................................27 
Figure S23. Crystal structure of [LFe3(PhPz)2(OArPz)OMn][OTf]2 (5) ....................................................28 
Special refinement details for complex 5. ....................................................................................................28 
Figure S24. Crystal structure of[LFe3(PhPz)2(OArPz)OMn][OTf]3 (6) .....................................................29 
Special refinement details for complex 6. ....................................................................................................29 
Table S1. Selected bond angles and distances for complexes 1, 2, 4–6 ......................................................30 
Table S2. Fe EXAFS curve-fitting parameters for complexes 1, 3, and 5 ..................................................31 
Table S3. Fe EXAFS curve-fitting parameters for complexes 2, 4, and 6 ..................................................32 
Table S4. Mn EXAFS curve-fitting parameters for complexes 1, 3, and 5 ................................................33 
Table S5. Mn EXAFS curve-fitting parameters for complexes 2, 4, and 6 ................................................34 
Table S6. Crystal and refinement data for complexes 1, 2, and 4 ...............................................................35 
Table S7. Crystal and refinement data for complexes 5 and 6 ....................................................................35 
Table S8. 57Fe zero-field Mössbauer parameters of complexes  1, 2, and 4–6 ...........................................36 
References ...................................................................................................................................................36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 S4 
General Considerations. 
 
All reactions were performed at room temperature in an N2-filled M. Braun Glovebox or by using 
standard Schlenk techniques unless otherwise specified. Glassware was oven dried at 140 °C for at least 
2h prior to use, and allowed to cool under vacuum. All reagents were used as received unless otherwise 
stated. Iodosobenzene (PhIO), 2-(tertbutylsulfonyl)iodosobenzene (sPhIO), sodium 3-(phenyl)pyrazolate 
and LFe3(OAc)(OTf)2 were synthesized according to published procedures.[S1-4] Caution! Iodosobenzene 
is potentially explosive and should be used only in small quantities. Phenyl-1H-pyrazole, Na(N(SiMe3)2), 
and AgOTf, were purchased from Sigma Aldrich, Oakwood Chemicals and Strem Chemicals. All 
pyrazoles were sublimed before use. Anhydrous tetrahydrofuran (THF) was purchased from Aldrich in 18 
L Pure-PacTM containers. Anhydrous CH2Cl2, diethyl ether, hexane and THF were purified by sparging 
with nitrogen for 15 minutes and then passing under nitrogen pressure through a column of activated A2 
alumina. Anhydrous 1,2-dimethoxyethane (DME) was dried over sodium/benzophenone and vacuum-
transferred onto molecular sieves. The 1H, 19F and 13C{1H} NMR spectra were recorded at 300.13, 
282.36, and 75.47 MHz, respectively, on a Varian 300 MHz spectrometer. All chemical shifts (δ) are 
reported in ppm, and coupling constants (J) are in Hz. The 1H and 13C{1H} NMR spectra were referenced 
using residual solvent peaks in the deuterated solvent. The 19F chemical shifts are reported relative to the 
internal lock signal. Deuterated solvents (CD2Cl2 and CD3CN) were purchased from Cambridge Isotope 
Laboratories, dried over calcium hydride, degassed by three freeze-pump-thaw cycles and vacuum-
transferred prior to use. The UV-vis spectra were recorded on a Varian Cary Bio 50 spectrophotometer. 
Fast atom bombardment-mass spectrometry (FAB-MS) analysis was performed with a JEOL JMS-600H 
high resolution mass spectrometer. Elemental analyses were performed at Caltech. 
 
Physical Methods. 
 
Electrochemical measurements. CVs were recorded with a Pine Instrument Company AFCBP1 
bipotentiostat using the AfterMath software package. All measurements were performed in a three-
electrode cell configuration that consisted of 1) a glassy-carbon (ø = 3.0 mm) working electrode, 2) a Pt 
wire as counter electrode, and 3) an Ag wire as reference electrode. All electrochemical measurements 
were performed at RT in an M. Braun N2-filled glovebox. Dry dichloromethane containing 0.1 M 
nBu4NPF6 was used as the electrolyte solution. The ferrocene/ferrocenium (Fc/Fc+) redox couple was used 
as an internal standard for all measurements. 
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Mössbauer spectroscopy. Zero-field 57Fe Mössbauer spectra were recorded at 80 K in the constant 
acceleration mode on a spectrometer from See Co (Edina, MN) equipped with an SVT-400 cryostat 
(Janis, Wilmington, WA). The quoted isomer shifts are relative to the centroid of the spectrum of a α-Fe 
foil at room temperature. Samples were prepared by grinding polycrystalline material (20 mg) into a fine 
powder and pressed into a homogeneous pellet with boron nitride in a cup fitted with a screw cap. The 
data were fitted using the program WMOSS (www.wmoss.org). All spectra were simulated by three pairs 
of symmetric quadrupole doublets with equal populations and Lorentzian lineshapes, and refined to a 
minimum by the method of least squares optimization. For all spectra, the observed resonances spanned 
the region from -1–3 mm s-1. Any resonances appearing above 2 mm s-1 indicate the presence of high spin 
FeII centers and must correspond to species with isomer shifts ~1 mm s-1, given the range of observed 
resonances. The Mössbauer data were modeled to be consistent with our previously reported triiron-
oxo/hydroxyl clusters, and our previously reported tetranuclear iron clusters.[S4, S5] Overall, the observed 
Mössbauer parameters are in-line with other six-coordinate FeII/FeIII centers bearing N- and O-donor 
atoms.[S6-13] For a detailed description on Mössbauer simulation and fitting in similar complexes, see: J. 
Am. Chem. Soc. 2016, 138, 1486-1489.[S14] The Mössbauer spectrum of 3 was not recorded due to 
solubility issues. Compound 3 is not stable in the solid state. For (frozen) solution-based studies, 
dichloromethane is not suitable for Mössbauer spectroscopy. Besides dichloromethane, 3 is only soluble 
in acetonitrile which freezes at a temperature higher than compound 3 is stable at, therefore preventing its 
observation. 
 
X-ray Absorption Spectroscopy (XAS).  X-ray absorption data at Mn and Fe K-edges were collected on 
bemline 7-3 at Stanford Sychrotron Radiation Laboratory (SSRL) under standard ring conditions of 3.0 
GeV and 500 mA current. A Si (220) double crystal monochromator was used for energy selection which 
was detuned to 50% of flux maximum at Mn and Fe K-edges. The intensities of incident and transmitted 
X-ray beam were monitored using N2-filled ion chambers before the sample (I0) and after the sample (I1), 
respectively. 20 mM solutions of samples in dichloromethane were loaded in 40 µL plexiglass sample 
holders with Mylar tape window on one side, and frozen immediately in liquid nitrogen. The powder 
samples of reference compounds were finely ground and diluted with boron nitride (1% w/w). The diluted 
mixtures were then packed in 0.5 mm thick aluminum sample holders and sealed with Kapton tape on 
both sides. For reference compounds, the spectra were collected in transmission mode whereas all other 
data were collected as fluorescence excitation spectra using 30-element Ge solid-state detector 
(Canberra). The monochromator energy was calibrated with the pre-edge peak of KMnO4 (6543.3 eV) for 
Mn K-edge data and first inflection point energy of Fe foil spectrum (7111.2 eV) for Fe K-edge 
measurements. The calibration standards were placed between the N2-filled ion chambers (I1 and I2) after 
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the sample. To minimize the X-ray damage, data was collected at 10 K using a liquid He flow cryostat 
(Oxford Instruments). The solution samples were closely monitored for photo-damage during the course 
of measurements. 
 Data reduction of XAS spectra was performed using SamView (SixPack software, available at  
http://www.sams-xrays.com/sixpack). Athena program of Demeter software package (Demeter version 
0.9.25, B. Ravel)[S15] was used to subtract the pre-edge and post-edge backgrounds from absorption 
spectra after which the spectra were normalized to the edge jump. A five-domain cubic spline was used to 
remove the background in k-space and resulting k-space data, k3χ(k), was then Fourier transformed (FT) 
into r-space. Fitting of the EXAFS data was performed in r-space with Artemis software (Demeter version 
0.9.25, B. Ravel) using ab initio phases and amplitudes calculated with the program FEFF6.[S16] These 
calculated phases and amplitudes were then used in the EXAFS equation. 
 
! " = $%&
'(
")(&(
*+,,-(/, ", )()2
-&4-5652-&7- 8- 6 9:;	[2")( + @A( " ] 
 
 
where neighboring atoms to the absorbing atom(s) are split into j shells, with all the atoms having same 
atomic number and distance from the central atom(s) grouped into a single shell. Nj is the coordination 
number representing the number of neighboring atoms in shell j at a distance Rj from the central atom(s). 
The term !"##$(&, (, )*)   denotes the ab initio amplitude function for shell j, and the Debye-Waller term 
!-#$%
&'&   accounts for the amplitude damping due to thermal and static disorder in absorber-backscatterer 
distances. The mean free path term !-#$% &% '   defines the losses due to inelastic scattering, where λj(k) 
denotes the electron mean free path. The EXAFS oscillations are reflected in the sinusoidal term, sin[2kRj 
+ φij(k)] where φij(k) is the ab initio phase function for shell j. !"#  takes into account the amplitude 
reduction factor due to shake-up/shake-off processes occurring at the central atom. During the curve 
fitting process, variable parameters included the bond distance between the absorbing atom and its nearest 
neighbors (Rj), and mean square displacement of the bond distance (!"#  ). The non-structural parameter E0 
(the energy which defines the zero value of the photoelectron wave vector k) was also varied but 
restricted to a common value for each component in a given fit. In case of each element, the value for the 
passive electron reduction factor (!"#  ) was determined from the fits to the data of respective reference 
standards, and was fixed during the fits (0.90 for Mn and 0.88 for Fe). Some multiple scattering paths 
were also included in the fits to improve the fit quality. 
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Fourier Transform (FT) of k3-weighted Mn and Fe EXAFS data for complexes 3-6 are shown in 
Figure S14-S16 along with the corresponding fits. It is important to note that x-axis represents the 
apparent distance (R’) which is shorter than the real scatter distance by ~0.5 Å resulting from the phase 
shift. The first peak in the FT data corresponds to metal-ligand (M-O/N, where M = Mn/Fe) scattering 
whereas second peak includes metal-metal/metal-ligand interactions (Mn-Fe, Fe-Fe M-C/N). The best fit 
parameters obtained for the fits are listed in Tables S2-S5. The uncertainty in the scattering pathlengths 
contributing to the second peak in Mn EXAFS is relatively higher for complex 4 as compare to complex 3 
(Table S4 and S5, both complexes have almost similar ligand environment). This is due the smaller signal 
to noise ratio in case of complex 4. The bond distance values for metal-ligand and metal-metal distances 
obtained from EXAFS are in good agreement with those determined from XRD wherever known. 
 For the the k3-weighted Fe EXAFS, almost similar k-space windows were used but the FT 
amplitudes are greater in case of complex 4 and 6 when compared with those of complexes 3 and 5. This 
originates from all the three Fe being in same oxidation state in complex 4 and 6, leading to less 
anisotropy of metal-ligand/metal-metal distances. The EXAFS curve fitting parameters for Fe K-edge are 
listed in Tables S2 and S3, and the extracted absorber-scatterer distances are similar to the ones obtained 
from XRD. 
 
Sample Preparation. All samples were prepared under air-free conditions in a N2-filled M. Braun 
Glovebox. Solution of compounds 1, 2, 5, and 6 (20 mM) in CD2Cl2 (1 mL) were frozen in the cold well. 
Upon thawing, the solutions were pipetted onto the frozen 40 µL XAS solution sample holders – cooled 
on a frozen aluminum metal disk (80 K) – with pre-cooled (80K) glass pipettes. The homogeneous 
solutions immediately froze upon contact with the sample holders, and were further frozen in the cold 
well to ensure complete cooling to 80 K. The remaining thawing solution was pipetted into a pre-cooled 
(80 K) J-Young NMR tube to ensure no decomposition had occurred (1H NMR was recorded at RT). 
Finally, the sample holders – containing the frozen solutions of 1, 2, 5, and 6 – were taken out of the 
glove box on the frozen aluminum metal disk, and immediately immersed into liquid nitrogen. The 
samples were subsequently introduced into cryotubeTM vials and stored at 80 K prior to measurements. 
Under no circumstances are the samples allowed to thaw above the freezing point of CD2Cl2.  
 
The iodosobenzene intermediates were generated in-situ. In general, in the glovebox 
[LFe3(PhPz)3OMn][OTf]x (0.02 mmol) was dissolved in CD2Cl2 (0.5 mL) and frozen in the cold well. To 
the frozen solution was added a thawing suspension of sPhIO (0.10 mmol) in CD2Cl2 (0.5 mL). The 
mixture was frozen in the cold well. When completely frozen, the samples were thawed until a solution 
was formed, whereupon the mixture was quickly mixed and refrozen in the cold well. This procedure was 
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repeated two times. During mixing the solution turned green (3) or remained purple (4). Next, while 
thawing, the solutions were quickly pipetted onto the frozen 40 µL XAS solution sample holders – cooled 
on a frozen aluminum metal disk (80 K) – with pre-cooled (80 K) glass pipettes inside the cold well. The 
homogeneous solutions immediately froze upon contact with the sample holders, and were further frozen 
in the cold well to ensure complete cooling to 80 K. The remaining thawing solution was pipetted into a 
pre-cooled (80 K) J-Young NMR tube to ensure the iodosobenzene adduct had formed (1H NMR was 
recorded at -70 °C (3) and at RT (4)). Finally the sample holders – containing the frozen solutions of 3 
and 4 – were taken out of the glove box on the frozen aluminum metal disk, and immediately immersed 
into liquid nitrogen. The samples were subsequently introduced into cryotubeTM vials and stored at 80 K 
prior to measurements. Under no circumstances are the samples allowed to thaw above the freezing point 
of CD2Cl2.  
 
X-ray crystallography.For compounds 1, 2 and 4–6, low-temperature (100 K) diffraction data (f-and w-
scans) were collected on a Bruker AXS D8 VENTURE KAPPA diffractometer coupled to a PHOTON 
100 CMOS detector with Mo Kα radiation (l = 0.71073 Å) or with Cu Kα (λ = 1.54178 Å). For 
compound 1, low-temperature (100 K) diffraction data (f-and w-scans) were collected on a Bruker AXS 
KAPPA APEX II diffractometer coupled to an APEX II CCD detector with graphite monochromated Mo 
Kα radiation (l = 0.71073 Å). All diffractometer manipulations, including data collection, integration, 
and scaling were carried out using the Bruker APEXII software.[S17] Absorption corrections were applied 
using SADABS.[S18] Structures were solved by direct methods using SHELXS[S19] and refined against F2 
on all data by full-matrix least squares with SHELXL-2014[S20] using established refinement 
techniques.[S21] All non-hydrogen atoms were refined anisotropically. All hydrogen atoms were included 
into the model at geometrically calculated positions and refined using a riding model. The isotropic 
displacement parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are 
linked to (1.5 times for methyl groups). All disordered atoms were refined with the help of similarity 
restraints on the 1,2- and 1,3-distances and displacement parameters as well as enhanced rigid bond 
restraints for anisotropic displacement parameters. Due to the size of compounds (1, 2 and 4–6), most 
crystals included solvent accessible voids, which tended to contain disordered solvent. In most cases, this 
disorder could be modeled satisfactorily Furthermore, the long-range order of these crystals and amount 
of high angle data was in some cases not ideal, due to desolvation of the crystals and/or solvent disorder. 
These disordered solvent molecules were largely responsible for the alerts generated by the checkCIF 
protocol.  
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Synthetic Procedures 
 
[LFe3(PhPz)3OMn][OTf]2 (1). In the glovebox, a suspension of LFe3(OAc)(OTf)2 (4148 mg, 3.0 mmol) 
in THF (40 mL) was frozen in the cold well. To the thawing suspension was added a thawing solution of 
NaPhPz (1690 mg, 10.0 mmol) in THF (10 mL). The color changed immediately to orange and the 
suspension became homogeneous during the course of 1 hour. The solution was stirred for a total of 2 
hours. Here after iodosobenzene (PhIO, 662 mg, 3.0 mmol) was added as a solid, and the solution 
changed to orange brown immediately and became homogenous after 0.5 h. The solution was stirred for 1 
h. and a brown precipitate formed. To the suspension was added Mn(OTf)2(MeCN)2 (2631 mg, 6.0 mmol) 
as a solid. The suspension was stirred for 24 h and subsequently filtered over a bed of Celite (0.5 cm) on a 
medium porosity glass frit. The remaining brown solid was dissolved in dichloromethane, filtered, and the 
solvent removed under reduced pressure to yield [LFe3(PhPz)3OMn][OTf]2 as a brown solid. Yield 
1916.6 mg (35%). X-ray quality crystals were obtained by diffusing diethyl ether into a concentrated 
solution of 1 in acetonitrile.  1H-NMR (300 MHz, CD2Cl2): δ 119.1 (br), 77.3 (br), 71.8 (s), 69.7 (s), 53.7 
(s), 51.2 (s), 44.6 (s), 15.2 (s), 13.4 (s), 9.6, 8.3 (s), -2.4 (br). 19F NMR (282 MHz, CD2Cl2): δ. -77.8. UV-
Vis (CH2Cl2) [ε (M-1 cm-1)]: 244 nm (16.4 × 104), 453 nm (11.1 × 103). Anal. calcd. (%) for 
C86H60F6Fe3MnN12O10S2: C 56.69, H 3.32, N 9.22; found: C 56.67, H 3.38, N 9.46. 
 
[LFe3(PhPz)3OMn][OTf]3 (2). In the glovebox, to a rapidly stirred solution of [LFe3(PhPz)3OMn][OTf]2 
(550 mg, 0.3 mmol) in CH2Cl2 (5.0 mL) was added – drop-wise – a solution of silver triflate (AgOTf; 79 
mg, 0.3 mmol) in CH2Cl2 (5.0 mL). The brown solution slowly changed color to dark purple. The solution 
was stirred for a further 2 h, and the solvent was removed under reduced pressure. The remaining solid 
was dissolved in a minimum amount of CH2Cl2 (~ 5.0 mL) and filtered over a bed of Celite (0.5 cm) on a 
medium porosity glass frit. The solvent was removed under reduced pressure to yield 
[LFe3(PhPz)3OFe][OTf]3 as a purple solid. Yield: 582 mg (98 %).  X-ray quality crystals were obtained 
by diffusing diethyl ether into a concentrated solution of 2 in acetonitrile. 1H-NMR (300 MHz, CD2Cl2): δ 
174.7 (br), 123.6 (br), 85.9 (s), 79.5 (br), 77.4 (br), 76.8 (br), 48.2 (s), 16.5 (s), 11.8 (s), -3.4 (s). 19F-NMR 
(282 MHz, CD2Cl2): -77.2 (s). UV-Vis (CH2Cl2) [ε (M-1 cm-1)]: 244 nm (10.8 × 104), 453 nm (8.8 × 103). 
Anal. calcd. (%) for C87H60F9Fe3MnN12O13S3: C 53.01, H 3.07, N 8.53; found: C 52.71, H 3.14, N 9.01. 
 
[LFe3(PhPz)3OMn(sPhIO)][OTf]2 (3). In the glovebox, in a J-Young NMR tube, a solution of 
[LFe3(PhPz)3OMn][OTf]2 (15.4 mg, 8.0 µmol) was dissolved in CD2Cl2 (0.50 mL) and frozen in the cold 
well. To this frozen solution was added sPhIO (14.0 mg, 41.1 µmol) in CD2Cl2 (0.50 mL). The NMR tube 
was taken out of the glovebox and stored in liquid nitrogen. The sample was subsequently warmed to  -78 
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°C (dry ice / acetone), mixed, and immediately thereafter, its 1H NMR spectrum was recorded at -70 °C. 
Inside the NMR machine, the sample was slowly warmed to RT, and spectra were taken at -50, -30, and -
10 °C, respectively, before the final spectrum was recorded at RT. The 1H-NMR spectrum at -70 °C 
shows a new paramagnetic 1H-NMR spectrum quite distict that of 2 (Figure S3), which converts to that of  
5 upon warming to RT (Figure S7). 1H-NMR (3; 300 MHz, CD2Cl2): δ 130.18 (br), 99.20 (br), 96.83 (br), 
82.10 (br), 70.04 (br), 64.31(br), 60.69 (br), 57.40 (br), 54.79 (br), 45.36 (br), 34.44 (br), 28.35 (br), 15.26 
(s), 14.12 (br). 
 
In a separate experiment; In a J-Young NMR tube, a solution of [LFe3(PhPz)3OMn][OTf]2 (17.6 mg, 9.8 
µmol) was dissolved in CD2Cl2 (0.50 mL) and frozen in the cold well. To this frozen solution was added 
sPhIO (18.9 mg, 49.9 µmol) in CD2Cl2 (0.50 mL). The frozen mixture was immediately transfered to a 
cold-bath at -78 °C (dry ice / acetone), to form the iodosobenzene intermediate. The solution was mixed 
and warmed to room temperature, whereupon the 1H NMR spectrum was immediately recorded (< 2 
min). Compound 5 was immediately formed upon warming to RT (Figure S10). 
 
[LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4). In the glovebox, in a J-Young NMR tube, a solution of 
[LFe3(PhPz)3OMn][OTf]3 (14.7 mg, 8.0 µmol) was dissolved in CD2Cl2 (0.50 mL) and frozen in the cold 
well. To this frozen solution was added sPhIO (13.5 mg, 41.1 µmol) in CD2Cl2 (0.50 mL). The NMR tube 
was taken out of the glovebox and stored in liquid nitrogen. The sample was subsequently warmed to  -78 
°C (dry ice / acetone, mixed, and immediately thereafter its 1H NMR spectrum was recorded at -78 °C. 
Inside the NMR machine the sample was slowly warmed to RT, and spectra were taken at -50, -30, and -
10 °C, respectively, before the final spectrum was recorded at RT (Figure S8). The 1H-NMR spectrum 
shows a new paramagnetic 1H-NMR spectrum quite distict that of 2 or 6 (Figure S4). Single crystals of 4 
were obtained by layering frozen solutions of 2 (15.0 mg, 7.6 µmol) in CH2Cl2 (0.45 mL), and (sPhIO 2.8 
mg, 8.4 µmol) in CH2Cl2 (0.55 mL), with toluene (1 mL) at -35 ºC, allowing the layers to mix during the 
course of two weeks. 1H-NMR (300 MHz, CD2Cl2): δ 151.9 (br), 120.1 (br), 76.0 (s), 70.0 (s), 67.7 (s), 
43.0 (s), 15.8 (s), 11.7 (s), -3.2 (s). 19F-NMR (282 MHz, CD2Cl2): δ -79.0 (s).  
 
In a separate experiment; In a J-Young NMR tube, a solution of [LFe3(PhPz)3OMn][OTf]3 (18.2 mg, 10.1 
µmol) was dissolved in CD2Cl2 (0.50 mL) and frozen in the cold well. To this frozen solution was added 
sPhIO (19.2 mg, 50.1 µmol) in CD2Cl2 (0.50 mL). The frozen mixture was immediately transfered to a 
cold-bath at -78 °C (dry ice / acetone), to form the iodosobenzene intermediate. The solution was mixed 
and warmed to room temperature, whereupon the 1H NMR spectrum was immediately recorded (< 2 
min). Compound 4 remained one of the major species at least 3.5 hours after mixing (Figure S10). 
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[LFe3(PhPz)2(OArPz)OMn][OTf]2 (5). In the glovebox, to a solution of [LFe3(PhPz)3OMn][OTf]2 
(908.0 mg; 0.5 mmol) in CH2Cl2 (15 mL), was added a suspension of iodosobenzene (PhIO; 116.6 mg; 
0.5 mmol) in CH2Cl2 (2 mL). The resulting suspension was stirred for ca. 16 h. where upon the mixture 
became a homogenous red/brown solution. The volatiles were removed under reduced pressure to yield a 
red/brown solid (948 mg), which was mainly [LFe3(PhPz)2(OArPz)OMn][OTf]2 as judged by 1H NMR. 
The crude solid was crystallized from MeCN/Et2O to give [LFe3(PhPz)2(OArPz)OMn][OTf]2 as 
red/brown crystals. Yield 207 mg (23%). 1H NMR (300 MHz, CD2Cl2) δ 161.4 (br), 158.8 (br), 155.8 
(br), 119.2 (br), 110.2 (br), 104.7 (s), 93.1 (s), 91.31 (s), 86.2 (s), 84.9 (s), 81.0 (s), 73.3 (s), 71.1 (s), 70.9 
(s), 69.3 (s), 67.3 (s), 67.0 (s), 58.1 (s), 57.9 (s), 56.9 (s), 17.3 (s), 17.0 (s), 15.1 (s), 14.5 (s), 13.5 (s), 12.6 
(br), 10.8 (s), 10.6 (s), -0.7 (s), -1.2 (s), -2.0 (s), -8.3 (br). 19F NMR (282 MHz, CD2Cl2) δ -77.9. UV-Vis 
(CH2Cl2) [ε (M-1 cm-1)]: 244 nm (17.3 × 104), 453 nm (9.4 × 103). Anal. calcd. (%) for 
C86H59F6Fe4N12O11S2: C 56.23, H 3.24, N 9.12; found: C 55.69, H 3.36, N 9.32. 
 
[LFe3(PhPz)2(OArPz)OMn][OTf]3 (6). Procedure A. In the glovebox, to a thawing solution of 
[LFe3(PhPz)3OMn][OTf]3 (74.5 mg, 0.04 mmol) in CH2Cl2 (5 mL) was added sPhIO (11.1 mg, 0.05 
mmol), resulting in a darkening of solution to brown-purple over two hours. After sixteen hours, the 
solvent was removed under reduced pressure to yield a brown-violet solid. The solid was triturated in 
benzene (3 mL) and filtered over a bed of celite (0.5 cm) on a medium porosity glass frit. The remaining 
brown-violet solid was dissolved in CH2Cl2, filtered, and dried under reduced pressure to yield 
[LFe3(PhPz)2(OArPhPz)OMn][OTf]3 (60.0 mg, 80 %). 1H-NMR (300 MHz, CD2Cl2): δ 102.8 (br), 91.2 
(br), 87.5 (br), 84.5 (br), 81.8 (br), 60.4 (br), 53.7 (br), 45.9 (br), 17.5 (s), 16.4 (s), 15.1 (s), 13.5 (s), 11.8 
(s), -2.7 (s), -6.6 (s), -9.5 (s), -18.9 (s). 19F-NMR (282 MHz, CD2Cl2): δ -78.3 (s). UV-Vis (CH2Cl2) [ε (M-
1 cm-1)]: 244 nm (22.5 × 104), 538 nm (10.8 × 103). We were not able to obtain compound 6 in sufficient 
purirty for elemental analysis. Compound 6 either decomposed upon standing, while crystallalization of 
the crude reaction mixure at low temperatures always included complex 2 (see procedure B and Figure 
S24 for details).  
 
Procedure B. In the glovebox, to a stirring solution of give [LFe3(PhPz)2(OArPz)OMn][OTf]2 (78.0 mg, 
0.04 mmol) in CH2Cl2 (3 mL) was added a suspension of AgOTf (11.5 mg, 0.05 mmol) in CH2Cl2 (2 
mL). The reaction was stirred for two hours and subsequently filtered over a bed of celite (0.5 cm) on a 
medium porosity glass frit. The filtrate was dried under reduced pressure to yield 
[LFe3(PhPz)2(OArPz)OMn][OTf]3 as a brown/violet solid. Yield 55.1 mg (65 %). X-ray quality crystals 
 S12 
were obtained by diffusing diethyl ether into a concentrated solution of 6 in acetonitrile.The 1H-NMR 
spectrum and 19F-spectrum are near-identical to that from Procedure A.  
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Figure S1. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]2 (1) in CD2Cl2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]3 (2) in CD2Cl2. 
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Figure S3. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn(sPhIO)][OTf]2 (3) in CD2Cl2 at -70 °C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4) in CD2Cl2. 
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Figure S5. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OMn][OTf]2 (5) in CD2Cl2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OMn][OTf]3 (6) in CD2Cl2. 
 S16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S7. VT 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]2 (1) after addition of sPhIO at 
– 70 °C in CD2Cl2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S8. VT 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]3 (2) after addition of sPhIO at 
– 78 °C in CD2Cl2. 
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Figure S9. Time dependent 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]2 (1) at RT after 
mixing with sPhIO at -78 °C in CD2Cl2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S10. Time dependent 1H NMR spectrum (300 MHz) of [LFe3(PhPz)3OMn][OTf]3 (2) at RT after 
mixing with sPhIO at -78 °C in CD2Cl2. 
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Figure S11. Cyclic voltammograms (A) [LFe3(PhPz)3OMn][OTf]2 (2) and (B) 
[LFe3(PhPz)2(OArPz)OMn][OTf]2 (5) at a scan rate of 100 mV s −1. CV’s were recorded in CH2Cl2 at a 
concentration of 2 mM, with glassy carbon, Pt-wire, and Ag-wire as the working, counter, and reference 
electrodes, respectively. nBu4NPF6 (0.1 M) was used as the supporting electrolyte. The measured open-
circuit potential (OCP) was ca. -0.375 V for both complexes. 
A) 
B) 
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Figure S12. Normalized Mn K-edge XANES spectra (recorded at 10 K) of compounds 1–6, compared to 
that of MnO (MnII), Mn2O3 (MnIII), and Mn3O4 (MnII/III). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S13. Normalized Fe K-edge XANES spectra (recorded at 10 K) of compounds 1–6, compared to 
that of FeCl2 (FeII) and  Fe2O3 (FeIII). 
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Figure S14. Fourier transforms of k3-weighted Mn EXAFS (A and B) and Fe EXAFS (C and D) for 
[LFe3(PhPz)3OMn][OTf]2 (1; A and C) and [LFe3(PhPz)3OMn][OTf]3 (2; B and D). The red traces are the 
fits to the Mn and Fe EXAFS data (black circles). The EXAFS curve-fitting parameters are summarized 
in Table S2–S5. 
 
 
 
 
 
 
 
 
A) B) 
C) D) 
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Figure S15. Fourier transforms of k3-weighted Mn EXAFS (A and B) and Fe EXAFS (C and D) for 
[LFe3(PhPz)3OMn(sPhIO)][OTf]2 (3; A and C) and [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4; B and D). The 
red traces are the fits to the Mn and Fe EXAFS data (black circles). The EXAFS curve-fitting parameters 
are summarized in Table S2–S5. 
 
 
 
 
 
 
 
 
A) B) 
C) D) 
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Figure S16. Fourier transforms of k3-weighted Mn EXAFS (A and B) and Fe EXAFS (C and D) for 
[LFe3(PhPz)2(OArPz)OMn][OTf]2 (5; A and C) and [LFe3(PhPz)2(OArPz)OMn][OTf]3 (6; B and D). The 
red traces are the fits to the Mn and Fe EXAFS data (black circles). The EXAFS curve-fitting parameters 
are summarized in Table S2–S5. 
 
 
 
 
 
 
 
 
 
A) B) 
C) D) 
 S23 
 
 
 
 
 
 
 
 
 
 
Figure S17. Zero-field 57Fe Mössbauer spectra recorded at 80 K of (A) [LFe3(PhPz)3OMn][OTf]2 (1; 
black dots), fitted to three quadrupole doublets. Simulation is shown in grey, with parameters: (i) d = 0.45 
mm/s, ½DEQ½= 0.46 mm/s (dashed orange trace); (ii) d = 0.48 mm/s, ½DEQ½= 0.89 mm/s (solid orange 
trace); and (iii) d = 1.14 mm/s, ½DEQ½= 3.22 mm/s (solid blue trace); (B) [LFe3(PhPz)3OMn][OTf]3 (2; 
black dots), fitted to three quadrupole doublets. Simulation is shown in grey, with parameters: (i) d = 0.45 
mm/s, ½DEQ½= 0.55 mm/s (dashed orange trace); (ii) d = 0.45 mm/s, ½DEQ½= 0.77 mm/s (dotted orange 
trace); and (iii) d = 0.45 mm/s, ½DEQ½= 1.01 mm/s (solid orange trace). Residuals are shown as black 
squares. 
 
 
 
 
 
 
 
 
 
 
Figure S18. Zero-field 57Fe Mössbauer spectra recorded at 80 K of [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4; 
black dots), fitted to three quadrupole doublets. Simulation is shown in grey, with parameters: (i) d = 0.42 
mm/s, ½DEQ½= 0.73 mm/s (dotted orange trace); (ii) d = 0.46 mm/s, ½DEQ½= 0.91 mm/s (solid orange 
trace); and (iii) d = 0.47 mm/s, ½DEQ½= 0.71 mm/s (dashed orange trace). Residuals are shown as black 
squares. 
A) B) 
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Figure S19. Zero-field 57Fe Mössbauer spectra recorded at 80 K of (A) 
[LFe3(PhPz)2(OArPz)OMn][OTf]2 (5; black dots), fitted to three quadrupole doublets. Simulation is 
shown in grey, with parameters: (i) d = 0.45 mm/s, ½DEQ½= 0.59 mm/s (dashed orange trace); (ii) d = 
0.47 mm/s, ½DEQ½= 1.08 mm/s (solid orange trace); and (iii) d = 1.11 mm/s, ½DEQ½= 3.08 mm/s (solid 
blue trace); (B) [LFe3(PhPz)2(OArPz)OMn][OTf]3 (6; black dots), fitted to three quadrupole doublets. 
Simulation is shown in grey, with parameters: (i) d = 0.43 mm/s, ½DEQ½= 0.76 mm/s (dashed orange 
trace); (ii) d = 0.44 mm/s, ½DEQ½= 0.98 mm/s (dotted orange trace); and (iii) d = 0.43 mm/s, ½DEQ½= 
1.09 mm/s (solid orange trace). Residuals are shown as black squares. 
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Figure S20. Crystal structure of [LFe3(PhPz)3OMn][OTf]2 (1). Thermal ellipsoids are shown at the 50% 
probability level. Hydrogen atoms, outer sphere counter ions, and co-crystallized solvents molecules are 
not shown for clarity.  
 
Special refinement details for complex 1. Compound [LFe3(PhPz)3OMn][OTf]2 (1) crystallizes in the 
monoclinic space group C2/c with one molecule in the asymmetric unit along with two triflate counter 
ions, 2.96 molecules of acetonitrile, and one molecule of diethyl ether. One of the two triflate counter ions 
is disordered of two positions and was refined with the help of similarity restraints on the 1,2- and 1,3-
distances and displacement parameters, as well as enhanced rigid bond restraints for anisotropic 
displacement parameters. Two of the four co-crystallized acetonitrile molecules are at special positions, 
whereas as one of them is also disorded with a diethyl ether molecule. The co-crystallized acetonitrile 
solvent molecules were refined with the help of similarity restraints on the 1,2- and 1,3-distances and on 
displacement parameters. The anisotropic displacement parameters were refined with enhanced rigid bond 
restraints. Both diethyl ether molecules are near special positions and were modeled as such. One of the 
diethyl ether molecules is disorded with an acetonitrile molecule. The diethyl ether molecules were 
refined with the help of direct distance restraints on the 1,2- and 1,3-distances and displacement 
parameters, together with enhanced rigid bond restraints on the anisotropic displacement parameters.  
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Figure S21. Crystal structure of [LFe3(PhPz)3OMn(MeCN)][OTf]3 (2). Thermal ellipsoids are shown at 
the 50% probability level. Hydrogen atoms, outer sphere counter ions, and co-crystallized solvents 
molecules are not shown for clarity. 
 
Special refinement details for complex 2. Compound [LFe3(PhPz)3OMn(MeCN)][OTf]3 (2) crystallizes 
in the monoclinic space group P21/c with two molecules in the asymmetric unit along with six triflate 
anions, 5.84 molecules of acetonitrile, and 1.58 molecules of diethyl ether. Three out of the six triflate 
anions are disordered of two positions and were refined with the help of similarity restraints on the 1,2- 
and 1,3-distances and displacement parameters, as well as enhanced rigid bond restraints for anisotropic 
displacement parameters. The acetonitrile molecules – including two of them that are disorded with an 
diethyl ether molecule, and one of them that is disordered with a triflate anion – were refined with the 
help of similarity restraints on the 1,2- and 1,3-distances and displacement parameters, while restraining 
the 1,2- and 1,3-distances with the help of direct distance restraints. The anisotropic displacement 
parameters for the acetonitrile molecules were refined with enhanced rigid bond restraints.  The diethyl 
ether molecules were refined with the help of direct distance restraints on the 1,2- and 1,3-distances and 
displacement parameters., together with enhanced rigid bond restraints. One diethyl ether is disorded over 
two positions, in close promixity to a disordered acetonitrile molecule, and could not be appropriately 
refined without restrainging to approximate isotropic behavior. Identical isotropic or anisotropic 
displacement parameters were used for C409 and C408. 
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Figure S22. Crystal structure of [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4). Thermal ellipsoids are shown at 
the 50% probability level. Hydrogen atoms, outer sphere counter ions, and co-crystallized solvents 
molecules are not shown for clarity. 
 
Special refinement details for complex 4.  Compound [LFe3(PhPz)3OMn(sPhIO)][OTf]3 (4) crystallizes 
in the monoclinic space group P21/n with one molecule in the asymmetric unit along with three triflate 
anions, 3.45 molecules of dichloromethane, and two molecules of toluene. The three triflate counter ions 
and the two co-crystallized toluene molecules were refined with the help of similarity restraints on the 
1,2- and 1,3-distances and displacement parameters, as well as enhanced rigid bond restraints for 
anisotropic displacement parameters. Both triflate counter ions anions and the co-crystallized toluene 
solvent molecules were modeled as a two component disorder for each individule molecule. The 
dichloromethane molecules are located in three independent positions and were disordered over five 
components, where their 1,2- and 1,3-distances and displacement parameters were refined with the help 
of similarity restaints. The anisotropic displacement parameters were refined with enhanced rigid bond 
restraints. 
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Figure S23. Crystal structure of [LFe3(PhPz)2(OArPz)OMn][OTf]2 (5). Thermal ellipsoids are shown at 
the 50% probability level. Hydrogen atoms, outer sphere counter ions, and co-crystallized solvents 
molecules are not shown for clarity. 
 
Special refinement details for complex 5.  Compound [LFe3(PhPz)2(OArPz)OMn][OTf]2 (5) crystallizes 
in the triclinic space group P-1 with one molecule in the asymmetric unit along with two triflate anions 
and 1.6 molecules of acetonitrile. The phenoxide group is disordered over three positions with the other 
two phenyl groups. The 1.6 molecules of acetonitrile are disordered over three positions. The aryl and 
phenoxide groups involved in this disorder were restrained to be flat. The 1,2- and 1,3-distances for all 
acetonitrile molecules were refined with the help of direct distance restraints. All disordered atoms were 
refined with the help of similarity restraints on the 1,2- and 1,3-distances and displacement parameters, as 
well as enhanced rigid bond restraints for anisotropic displacement parameters. The crystal was non-
merohedrally twinned. Two independent orientation matrices for the unit cell were determined using the 
program CELL_NOW, and data reduction taking into account the twinning was performed with SAINT. 
The program TWINABS was used to perform absorption correction and scaling, and to set up the HKLF5 
format file for structure refinement. The twin ratio was refined freely and converged at a value of 
0.335(1).  
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Figure S24. Crystal structure of [LFe3(PhPz)2(OArPz)OMn][OTf]3 (6). Thermal ellipsoids are shown at 
the 50% probability level. Hydrogen atoms, outer sphere counter ions, and co-crystallized solvents 
molecules are not shown for clarity. 
 
Special refinement details for complex 6.  Compound [LFe3(PhPz)2(OArPz)OMn][OTf]3 (6) crystallizes 
in the trigonal space group R3-c with one third of a molecule in the asymmetric unit along with one 
triflate anion and 2.68 molecules of acetonitrile. The phenoxide moiety was disordered with coordinated 
acetonitrile. This disorder accounts for ca. ~15% inclusion of [LFe3(PhPz)3OMn][OTf]3 (2), which were 
we not able to remove. Crystallization attempts usually resulted in decomposition of 6 or inclusion of 2. 
The current crystal structure is one of the best we were able to obtain, despite multiple attempts. The 
triflate anion was modeled as a two component disorder. The co-crystallized acetonitrile molecules was 
modeled as seven components over four independent positions, two of which are located near 
crystallographic symmetry elements. The triflate counter ions and the co-crystallized acetonitrile 
molecules were refined with the help of similarity restraints on the 1,2- and 1,3-distances and 
displacement parameters, as well as enhanced rigid bond restraints for anisotropic displacement 
parameters. Both triflate counter ions anions and the co-crystallized solvent molecules were modeled as a 
two- or multi-component disorder for each individule molecule. 
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Table S1. Selected bond angles and distances for complexes 1, 2, 4–6. 
 
Bond Distance (Å) Complex 
 1 2 a 4 5b 6c 
Fe1–O1 2.079(2) 1.971(3) 1.996(7) 2.140(5) 2.031(2) 
Fe2–O1 1.999(3) 1.992(3) 1.974(7) 2.009(4) 2.031(2) 
Fe3–O1 1.937(2) 1.986(3) 1.990(7) 2.007(4) 2.031(2) 
Fe1–N13 2.116(3) 2.058(4) 2.062(8) 2.112(6) 2.040(4) 
Fe2–N23 2.115(3) 2.053(4) 2.037(9) 2.069(6) 2.040(4) 
Fe3–N33 2.078(3) 2.050(4) 2.028(9) 2.058(6) 2.040(4) 
Mn1–N14 2.101(3) 2.150(4) 2.169(9) 2.046(6) 2.057(4) 
Mn1–N24 2.117(3) 2.146(4) 2.164(9) 2.120(6) 2.057(4) 
Mn1–N34 2.112(3) 2.155(4) 2.162(12) 2.021(6) 2.057(4) 
Mn1-N1 - 2.200(4) - - - 
N13–N14 1.384(4) 1.390(5) 1.365(12) 1.380(8) 1.380(5) 
N23–N24 1.388(4) 1.380(5) 1.382(13) 1.411(8) 1.380(5) 
N33–N34 1.380(4) 1.387(5) 1.432(15) 1.385(8) 1.380(5) 
Mn1–O1 1.980(2) 2.116(3) 2.100(6) 1.876(4) 1.943(4) 
Mn1–O2 - - 2.052(9) 1.842(7) 1.820(9) 
      
Bond Angles (º)      
N14–Mn1–N24 119.07(12) 118.26(14) 113.5(4) 115.1(2) 119.68(2) 
N24–Mn1–N34 120.37(12) 117.00(14) 127.1(4) 118.4(2) 119.68(2) 
N34–Mn1–N14 120.56(12) 120.32(14) 114.6(4) 126.1(2) 119.68(2) 
O1–Mn1–O2 - - 174.3(4) 170.6(3) 164.0(3) 
O1–Mn1–N1 - 178.54(13) - - - 
aBond angles and distances are taken from with the disordered part of 2 with a chemical occupancy of 65.9%. 
bBond angles and distances are taken from only one (component A) of the two molecules in the unit cell.  
cThe molecule crystallizes in the trigonal space group R3-c, so most bond paramters are generated by symmetry 
operations. 
 
 
 
 
 
 
 
 
 
 
 
 
 S31 
Table S2. Fe EXAFS curve-fitting parameters for complexes 1, 3, and 5.a 
 
# Path R (Å) N σ2 (10-3 Å2) R (%) ΔE0 
  EXAFS XRD     
1 
Fe-O 1.95±0.04   2.02 3 5.42±2.59 0.60 -0.92±3.05 
Fe-N 2.13±0.03   2.15 3 2.00±1.80   
Fe-C 2.88±0.07  4 19.9±1.36   
Fe-N 2.93±0.07  1 19.9±0.55   
Fe-Fe 3.05±0.02  2 3.69±2.37   
Fe-C 3.00±0.07  3 6.82±3.90   
Fe-N-N 3.19±0.04  2 3.31±2.00   
Fe-N-C 3.24±0.04  10 3.31±2.00   
Fe-Mn 3.46±0.05  1 4.04±6.18   
3 
Fe-O 1.97±0.04 N/A 3 3.57±4.14 0.60 -0.96±3.22 
Fe-N 2.14±0.05 N/A 3 2.20±1.80   
Fe-C 2.91±0.09  4 19.9±1.36   
Fe-N 2.96±0.09  1 19.9±0.55   
Fe-Fe 3.03±0.03  2 3.04±2.51   
Fe-C 3.03±0.09  3 6.82±3.90   
Fe-N-N 3.22±0.04  2 3.31±2.00   
Fe-N-C 3.27±0.04  10 3.31±2.00   
Fe-Mn 3.46±0.06  1 4.04±6.18   
5 
Fe-O 1.98±0.03 2.03 3 4.75±5.64 0.95 -0.22±2.88 
Fe-N 2.12±0.06 2.14 3 2.20±1.80   
Fe-C 2.92±0.09  4 19.9±1.36   
Fe-N 2.98±0.09  1 19.9±0.55   
Fe-Fe 3.03±0.04  2 3.44±2.28   
Fe-C 3.04±0.09  3 6.82±3.90   
Fe-N-N 3.22±0.03  2 2.99±3.05   
Fe-N-C 3.27±0.03  10 2.99±3.05   
Fe-Mn 3.41±0.09  1 19.9±0.10   
 
aEXAFS fitting for complex 1 was performed over the k-range 2.39≤ k(Å-1) ≥ 10.46 (1.0 ≤ 
R’(Å)  ≥ 3.4). Complex 3 was fit over the k-range 2.39≤ k(Å-1) ≥ 10.10 (1.0 ≤ R’(Å)  ≥ 3.5). 
EXAFS data of complex 5 was fit in the k-range 2.39≤ k(Å-1) ≥ 10.10 (1.0 ≤ R’(Å)  ≥ 3.4). 
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Table S3. Fe EXAFS curve-fitting parameters for complexes 2, 4, and 6.a 
 
# Path R (Å) N σ2 (10-3 Å2) R (%) ΔE0 
  EXAFS XRD     
2 
Fe-O 1.98±0.02 2.01 3 3.43±2.81 0.60 2.28±1.64 
Fe-N 2.11±0.02 2.11 3 2.20±1.80   
Fe-C 2.91±0.05  4 19.9±1.36   
Fe-N 2.96±0.05  1 19.9±0.55   
Fe-Fe 3.03±0.02  2 2.08±2.51   
Fe-C 3.03±0.05  3 3.20±2.42   
Fe-N-N 3.22±0.02  2 2.00±2.31   
Fe-N-C 3.27±0.02  10 2.00±2.31   
Fe-Mn 3.46±0.04  1 2.22±1.23   
4 
Fe-O 1.97±0.02 2.01 3 2.00±1.65 0.94 2.72±2.53 
Fe-N 2.11±0.04 2.12 3 2.20±1.80   
Fe-C 2.91±0.07  4 19.9±1.36   
Fe-N 2.96±0.07  1 19.9±0.55   
Fe-Fe 3.03±0.02  2 2.07±2.38   
Fe-C 3.03±0.07  3 4.33±4.24   
Fe-N-N 3.21±0.02  2 2.03±3.05   
Fe-N-C 3.26±0.02  10 2.05±3.05   
Fe-Mn 3.47±0.06  1 2.22±1.23   
6 
Fe-O 1.98±0.02 2.02 3 3.53±6.37 0.55 2.43±1.46 
Fe-N 2.10±0.02 2.10 3 2.20±1.80   
Fe-C 2.91±0.05  4 19.9±0.40   
Fe-N 2.97±0.05  1 19.9±0.55   
Fe-Fe 3.05±0.02  2 2.96±2.96   
Fe-C 3.03±0.05  3 8.28±2.78   
Fe-N-N 3.22±0.02  2 2.00±2.63   
Fe-N-C 3.28±0.02  10 2.00±2.63   
Fe-Mn 3.40±0.07  1 7.28±6.30   
 
aEXAFS fitting for complex 2 was performed over the k-range 2.54≤ k(Å-1) ≥ 10.68 (1.0 ≤ R’(Å)  ≥ 3.4). For complex 
4, the data was fit over the k-range 2.54≤ k(Å-1) ≥ 10.10 (1.0 ≤ R’(Å)  ≥ 3.4). EXAFS data for complex 6 was fit in the 
k-range 2.54≤ k(Å-1) ≥ 10.10 (1.0 ≤ R’(Å)  ≥ 3.5). 
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Table S4. Mn EXAFS curve-fitting parameters for complexes 1, 3, and 5.a 
 
# Path R (Å) N σ2 (10-3 Å2) R (%) ΔE0 
  EXAFS XRD     
1 
Mn-O 2.00±0.03 1.98 1 2.00±1.00 1.96 3.02±2.99 
Mn-N 2.11±0.03 2.11 3 2.00±1.00   
Mn-N 3.01±0.05  3 2.00±1.00   
Mn-N-N 3.27±0.05  6 6.20±5.98   
Mn-C 3.29±0.05  3 2.00±1.00   
Mn-N-C 3.38±0.05  6 20.0±2.00   
Mn-Fe 3.44±0.03  3 4.96±4.16   
Mn-C 3.52±0.09  3 2.00±1.00   
       
 Mn-C 3.83±0.09  3 2.00±1.00   
3 
Mn-O 2.03±0.02 N/A 2 2.00±1.00 1.49 3.02±2.51 
Mn-N 2.18±0.03 N/A 3 2.00±1.00   
Mn-N 3.02±0.06  3 3.00±1.00   
Mn-N-N 3.28±0.06  6 10.8±4.67   
Mn-C 3.23±0.09  3 2.00±1.00   
Mn-N-C 3.34±0.09  6 20.0±2.00   
Mn-Fe 3.46±0.05  3 6.36±3.40   
Mn-C 3.48±0.10  3 2.00±1.00   
Mn-I 3.70±0.07  1 2.78±3.76   
Mn-C 3.71±0.09  3 7.00±6.30   
5 
Mn-O 1.86±0.01 1.89 2 2.00±1.25 0.50 5.51±1.22 
Mn-N 2.08±0.02 2.06 3 12.0±5.20   
Mn-C 2.92±0.01  1 2.00±1.00   
Mn-N 2.95±0.01  3 4.00±2.54   
Mn-O-C 3.06±0.01  2 20.0±2.00   
Mn-C73 3.15±0.01  3 20.0±2.00   
Mn-N-N 3.23±0.02  6 14.9±5.25   
Mn-N-C 3.28±0.02  6 2.00±1.81   
Mn-Fe 3.39±0.02  3 6.73±2.17   
Mn-C 3.45±0.01  1 2.00±1.00   
 
aEXAFS fitting for complex 1 as well as complex 3 was performed over the k-range 2.37≤ k(Å-1) ≥ 10.74 (1.0 ≤ R’(Å)  
≥ 3.5). EXAFS data of complex 5 was fit in the k-range 2.37≤ k(Å-1) ≥ 11.02 (1.0 ≤ R’(Å)  ≥ 3.5). 
 
 
 
 S34 
Table S5. Mn EXAFS curve-fitting parameters for complexes 2, 4, and 6.a 
 
# Path R (Å) N σ2 (10-3 Å2) R (%) ΔE0 
  EXAFS XRD     
2 
Mn-O 2.06±0.03 2.12 1 2.00±1.00 1.71 4.39±1.53 
Mn-N 2.14±0.02 2.15 3 2.00±1.00   
Mn-N 3.02±0.04  3 2.00±1.00   
Mn-N-N 3.28±0.04  6 7.86±5.48   
Mn-C 3.31±0.09  3 2.00±1.00   
Mn-N-C 3.42±0.09  6 20.0±1.00   
Mn-Fe 3.47±0.03  3 3.71±3.30   
Mn-C 3.44±0.08  3 8.61±1.20   
       
Mn-C 3.77±0.09  3 6.00±2.68   
4 
Mn-O 2.06±0.03 2.07 2 2.00±1.00 1.21 3.81±3.46 
Mn-N 2.20±0.03 2.16 3 2.00±1.00   
Mn-N 3.03±0.06  3 3.00±1.00   
Mn-N-N 3.29±0.06  6 2.22±1.10   
Mn-C 3.28±0.13  3 2.00±1.00   
Mn-N-C 3.40±0.13  6 20.0±2.00   
Mn-Fe 3.48±0.06  3 9.89±7.83   
Mn-C 3.50±0.11  3 2.00±1.00   
Mn-I 3.74±0.08  1 3.96±3.92   
Mn-C 3.75±0.13  3 7.00±6.30   
6 
Mn-O 1.86±0.03 1.88 2 2.00±1.25 1.77 5.20±3.83 
Mn-N 2.05±0.05 2.06 3 8.52±2.93   
Mn-C 2.92±0.04  1 2.00±1.00   
Mn-N 2.95±0.04  3 4.61±3.89   
Mn-O-C 3.06±0.03  2 20.0±2.00   
Mn-C73 3.15±0.04  3 20.0±2.00   
Mn-N-N 3.20±0.05  6 16.0±3.92   
Mn-N-C 3.25±0.05  6 2.00±1.81   
Mn-Fe 3.39±0.04  3 4.75±3.39   
Mn-C 3.45±0.04  1 2.00±1.00   
 
aEXAFS data of complex 2 was fit for the k-range 2.37≤ k(Å-1) ≥ 10.74 (1.0 ≤ R’(Å)  ≥ 3.5). Due to poor signal/noise 
between the k-range 10-12 Å, EXAFS data for complex 4 was fit for the k-range 2.37≤ k(Å-1) ≥ 10.00 (1.0 ≤ R’(Å)  ≥ 
3.5). EXAFS fitting for complex 6 was carried out over the k-range 2.37≤ k(Å-1) ≥ 11.02 (1.0 ≤ R’(Å)  ≥ 3.5). 
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Table S6. Crystal and refinement data for complexes 1, 2, and 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S7. Crystal and refinement data for complexes 5 and 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Complex 1 Complex 2 Complex 4 
CCDC 1536076 1536078 1536079 
Empirical 
formula 
C94.73H75.91F6Fe3MnN14.96 
O10.64S2 
C98H79.56F9Fe3MnN15.96 
O13.77S3 
C114.45H95.9Cl6.91F9Fe3IMn
N12O16S4 
Formula 
weight (g/mol) 1994.54 2190.72 2788.77 
T (K) 100 100 100 
Radiation MoKa (l = 0.71073) MoKa (l = 0.71073) MoKa (l = 0.71073) 
a (Å) 24.476(2) 24.7643(9) 17.0307(14) 
b (Å) 30.706(2) 27.4050(11) 28.110(2) 
c (Å) 24.9321(18) 29.9653(18) 23.8087(19) 
α (deg) 90 90 90 
β (deg) 95.471(3) 106.821(2) 95.745(3) 
γ (deg) 90 90 90 
V (Å3) 18653(2) 19466.3(16) 11340.7(16) 
Z 8 8 4 
Cryst. syst. monoclinic monoclinic monoclinic 
Space group C2/c P21/c P21/n 
ρcalcg (cm3) 1.420 1.495 1.633 
2 σ range (deg) 4.458 to 62.584 4.368 to 56.56 4.498 to 46.512 
Crystal 
size/mm 0.20 × 0.10 × 0.10 0.19 × 0.13 × 0.11 0.25 × 0.14 × 0.07 
µ (mm-1) 0.714 0.719 1.080 
GOF 1.038 1.039 1.110 
R1, wR2 (I> 
2σ (I)) R1 = 0.0773, wR2 = 0.1941 R1 = 0.0751, wR2 = 0.1823 R1 = 0.1100, wR2 = 0.3050 
 Complex 5 Complex 6  
CCDC 1536077 1536080  
Empirical 
formula 
C89.32H63.97F6Fe3MnN13.66O
11.02S2 
C103.46H83.87F9Fe3MnN20.23
O13.82S3 
 
Formula weight 
(g/mol) 1905.43 2321.28  
T (K) 100 100  
Radiation MoKa (l = 0.71073) CuKα (λ = 1.54178)  
a (Å) 15.4913(11) 20.4157(5)  
b (Å) 16.6033(11) 20.4157(5)  
c (Å) 17.5539(12) 89.236(2)  
α (deg) 85.763(2) 90  
β (deg) 85.364(2) 90  
γ (deg) 64.5531(19) 120  
V (Å3) 4059.8(5) 32210.7(18)  
Z 2 12  
Cryst. syst. triclinic trigonal  
Space group P-1 R3-c  
ρcalcg (cm3) 1.559 1.436  
2 σ range (deg) 5.282 to 52.804 5.376 to 158.69  
Crystal 
size/mm 0.25 × 0.25 × 0.20 0.20 × 0.20 × 0.20  
µ (mm-1) 0.816 5.404  
GOF 1.102 1.057  
R1, wR2 (I> 2σ 
(I)) R1 = 0.0955, wR2 = 0.1778 R1 = 0.0762, wR2 = 0.2167  
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Table S8. 57Fe zero-field Mössbauer parameters of complexes  1, 2, and 4–6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Complex Parameters 
  δ (mm/s) 
| Δ Eq | 
(mm/s) 
Γ (mm s-1) 
Relative area 
(%) 
      
1 [LFe3(PhPz)3OMn][OTf]2 
0.45 
0.48 
1.14 
0.46 
0.89 
3.22 
0.41 
0.39 
0.56 
36 
36 
36 
      
2 [LFe3(PhPz)3OMn][OTf]3 
0.45 
0.45 
0.45 
0.55 
0.77 
1.01 
0.32 
0.26 
0.33 
34 
34 
34 
      
4 LFe3(PhPz)3OMn(sPhIO)][OTf]3 
0.42 
0.46 
0.47 
0.76 
0.93 
0.71 
0.33 
0.29 
0.25 
34 
34 
34 
      
5 LFe3(PhPz)2(OArPz)OMn][OTf]2 
0.45 
0.47 
1.11 
0.59 
1.08 
3.08 
0.47 
0.46 
0.60 
37 
37 
37 
      
6 LFe3(PhPz)2(OArPz)OMn][OTf]3 
0.43 
0.44 
0.44 
1.08 
0.76 
0.98 
0.39 
0.28 
0.27 
35 
35 
35 
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